ARWR
Companies
NASDAQ
Arrowhead Pharmaceuticals Inc.
Health Care
$15.50
-$3.18 (-16.91%)
Price Chart
Overview
About ARWR
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
Market Cap
$3.0B
Volume
30.6M
Avg. Volume
31.4M
P/E Ratio
-3.722749
Dividend Yield
0.00%
Employees
451.0
Company Information
Latest News for ARWR
Jim Cramer: Arrowhead Pharmaceuticals Doesn't 'Have The Horses'
June 4, 2025
Growth stocks remain resilient in weakening economy, says Neuberger's Jason Tauber
July 8, 2022
Will Arrowhead Stock Rebound After A Large 30% Decline Last Week?
July 7, 2021
Arrowhead (ARWR) to Report Q1 Earnings: What's in the Cards?
February 3, 2020
Risk & Correlation Analysis
Market Correlation
0.90
Moderate Correlation
Volatility
High (0.64)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
High Sensitivity
Liquidity
High Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, ARWR shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$3.0B
Volume30.6M
P/E Ratio-3.72
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 13, 2025Related Securities
Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025